Search
Qiagen NV
QGENAdd to Watchlist
32.690USD
-1.010-3.00%
Close 05/13, 16:00（ET）Quotes delayed by 15 min
6.74BMarket Cap
17.49P/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-3.00%
5 Days
-3.85%
1 Month
-20.05%
6 Months
-26.71%
Year to Date
-27.43%
1 Year
-23.91%
TradingKey Stock Score of Qiagen NV
Currency: USD Updated: 2026-05-12Key Insights
Qiagen NV's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 18 out of 383 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 46.99.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Qiagen NV's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Qiagen NV Highlights
StrengthsRisks
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.09B.
Undervalued
The company’s latest PE is 18.03, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 161.40M shares, decreasing 15.71% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 238.76K shares of this stock.
Analyst Rating
Based on
18
analysts
Buy
Current Rating
46.989
Target Price
+42.22%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Qiagen NV News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Qiagen NV Info
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Ticker SymbolQGEN
CompanyQiagen NV
CEOBernard (Thierry)
Websitehttps://www.qiagen.com/
Related Instruments
+2.63%
+1.70%
+2.76%
+0.31%
+1.05%
+0.97%
+0.07%
-1.42%
+0.18%
+0.33%
+1.10%
-0.11%
+0.21%
-1.03%
+0.35%
-0.48%
0.00%
+1.25%
-1.19%
+2.11%Popular Instruments
98.112
-1.187 (-1.20%)
298.950
+4.150 (+1.41%)
225.890
+5.110 (+2.31%)
4687.530
-41.590 (-0.88%)
494.140
+5.400 (+1.10%)
1447.195
-4.825 (-0.33%)
803.140
+36.560 (+4.77%)
402.600
+15.250 (+3.94%)
79668.950
-997.920 (-1.24%)
445.230
+11.780 (+2.72%)
